Abstract:The modern healthcare system faces an unrelenting threat from microorganisms, as evidenced by global outbreaks of new viral diseases, emerging antimicrobial resistance, and the rising incidence of healthcare-associated infections (HAIs). An effective response to these threats requires rapid and accurate diagnostic tests that can identify causative pathogens at the point of care (POC). Such tests could eliminate diagnostic uncertainties, facilitating patient triaging, minimizing the empiric use of antimicrobial drugs, and enabling targeted treatments. Current standard methods, however, often fail to meet the needs of rapid diagnosis in POC settings. Culture-based assays entail long processing times and require specialized laboratory infrastructure; nucleic acid (NA) tests are often limited to centralized hospitals due to assay complexity and high costs. Here we discuss two new POC tests developed in our groups to enable the rapid diagnosis of infection. The first is nanoPCR that takes advantages of core-shell magnetoplasmonic nanoparticles (MPNs): (i) Au shell significantly accelerates thermocycling via volumetric, plasmonic light-to-heat conversion and (ii) a magnetic core enables sensitive in situ fluorescent detection via magnetic clearing. By adopting a Ferris wheel module, the system expedites multisamples in parallel with a minimal setup. When applied to COVID-19 diagnosis, nanoPCR detected SARS-CoV-2 RNA down to 3.2 copy/μL within 17 min. In particular, nanoPCR diagnostics accurately identified COVID-19 cases in clinical samples (n = 150), validating its clinical applicability. The second is a polarization anisotropy diagnostic (PAD) system that exploits the principle of fluorescence polarization (FP) as a detection modality. Fluorescent probes were designed to alter their molecular weight upon recognizing target NAs. This event modulates the probes' tumbling rate (Brownian motion), which leads to changes in FP. The approach is robust against environmental noise and benefits from the ratiometric nature of the signal readout. We applied PAD to detect clinically relevant HAI bacteria (Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus). The PAD assay demonstrated detection sensitivity down to the single bacterium level and determined both drug resistance and virulence status. In summary, these new tests have the potential to become powerful tools for rapid diagnosis in the infectious disease space. They do not require highly skilled personnel or labor-intensive analyses, and the assays are quick and cost-effective. These attributes will make nanoPCR and PAD well-aligned with a POC workflow to aid physicians to initiate prompt and informed patient treatment.

Plasmonic-based Platforms for Diagnosis of Infectious Diseases at the Point-of-care

Plasmonic Fluorescence Sensors in Diagnosis of Infectious Diseases

Plasmonic Nano-Arrays for Ultrasensitive Bio-Sensing

Construction of Plasmonic Nano‐Biosensor‐Based Devices for Point‐of‐Care Testing

Plasmonic Biosensors for Single-Molecule Biomedical Analysis

Multiplexed Biosensing of Proteins and Virions with Disposable Plasmonic Assays

Point-of-care diagnostics for infectious diseases: From methods to devices

Recent advances in surface-enhanced Raman scattering-based microdevices for point-of-care diagnosis of viruses and bacteria

Plasmonic and metamaterial biosensors: a game-changer for virus detection

A plasmonic mesoporous gold-based SERS-microfluidic platform for the detection of infectious diseases

Plasmonic Biosensors with Nanostructure for Healthcare Monitoring and Diseases Diagnosis

Highly sensitive detection of infected red blood cells (IRBCs) with plasmodium falciparum using surface plasmon resonance (SPR) nanostructure

Liquid-metal-based microfluidic nanoplasmonic platform for point-of-care naked-eye antibody detection

Development of Integrated Systems for On-Site Infection Detection

Multiplex Detection of Infectious Diseases on Microfluidic Platforms

Localized Surface Plasmon Resonance Biosensing: Current Challenges and Approaches

Flexible Plasmonic Biosensors for Healthcare Monitoring: Progress and Prospects

LAMP-Based Point-of-Care Biosensors for Rapid Pathogen Detection

A comprehensive review on plasmonic-based biosensors used in viral diagnostics

Lateral flow immunoassay based on surface-enhanced Raman scattering using pH-induced phage-templated hierarchical plasmonic assembly for point-of-care diagnosis of infectious disease

Microfluidic devices integrated with plasmonic nanostructures for sensitive fluorescent immunoassays